{"id":61637,"date":"2024-03-03T08:58:06","date_gmt":"2024-03-03T08:58:06","guid":{"rendered":"https:\/\/medsname.com\/glynase-mf\/"},"modified":"2026-05-08T09:15:21","modified_gmt":"2026-05-08T09:15:21","slug":"glynase-mf","status":"publish","type":"product","link":"https:\/\/medsbase.com\/da\/glynase-mf\/","title":{"rendered":"Glynase-MF"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Glynase-MF?<\/h3>\n<p style=\"margin:0;\"><strong>Glynase-MF<\/strong> er en tablet med fast dosiskombination, der indeholder <strong>Glipizide (5 mg)<\/strong> og <strong>metformin (500 mg)<\/strong> til behandling af <strong>type 2-diabetes<\/strong>. It combines two complementary mechanisms in a single tablet: metformin reduces the liver&rsquo;s glucose output and improves insulin sensitivity, while glipizide stimulates the pancreas to release more insulin. Usual dose is one tablet twice daily with breakfast and dinner. Typical HbA1c reduction: <strong>1,5\u20132,0 procentpoint<\/strong>. Main side effects: GI upset from metformin (first 1&ndash;2 weeks) and hypoglycaemia from the sulfonylurea. Glipizide has inactive metabolites and a shorter duration than glibenclamide &mdash; a safer sulfonylurea profile for most patients. Avoid in severe renal impairment (eGFR &lt; 30), decompensated heart failure, acute illness with dehydration, and sulfa allergy.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Hvad du f\u00e5r med MedsBase:<\/strong> WHO-GMP certificeret producent \u00b7 Diskret emballage \u00b7 Verdensomsp\u00e6ndende forsendelse \u00b7 1.400+ verificerede <a href=\"https:\/\/medsbase.com\/da\/reviews\/\">kundeanmeldelser<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Hver ordre er d\u00e6kket af vores <a href=\"https:\/\/medsbase.com\/da\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis din pakke ikke ankommer inden for 20 hverdage, sender vi en erstatning.<\/p>\n<h3>Hvorfor bestille fra MedsBase<\/h3>\n<p>Vores generiske medicin kommer fra WHO-GMP certificerede producenter og sendes verdensomsp\u00e6ndende i diskret, neutral emballage \u2014 ingen medicinnavn p\u00e5 pakkens ydre. Kortbetalinger h\u00e5ndteres af en reguleret processor (kontoudtogsbeskrivelser inkluderer en reguleret betalingsprocessor \u2014 aldrig \u201cMedsBase\u201d eller medicinnavn). Crypto og SEPA bankoverf\u00f8rsel accepteres ogs\u00e5. Hver ordre er d\u00e6kket af vores Reshipment Assurance Policy.<\/p>\n<h2 class=\"wp-block-heading\">What Is Glynase-MF?<\/h2>\n<p>Glynase-MF is a <strong>fast dosiskombination (FDC)<\/strong> oral antidiabetisk medicin, der indeholder to aktive ingredienser: <strong>Glipizide (5 mg)<\/strong> og <strong>metformin hydrochlorid (500 mg)<\/strong>, fremstillet af USV Pharma. Tilg\u00e6ngelig i pakker med 30, 60, 90 eller 180 tabletter.<\/p>\n<p>Combination tablets simplify the regimen (one tablet instead of two), improve adherence, and are typically less expensive than the two components bought separately. Glynase-MF is usually prescribed when metformin monotherapy is not achieving HbA1c targets.<\/p>\n<h2 class=\"wp-block-heading\">How Does Glynase-MF Work?<\/h2>\n<p>De to komponenter bek\u00e6mper hyperglyk\u00e6mi fra forskellige vinkler \u2014 dette er grunden til, at kombinationsterapi er mere effektivt end at \u00f8ge dosis af enten l\u00e6gemiddel alene:<\/p>\n<ul>\n<li><strong>Metformin<\/strong> \u2014 reducerer leverens glukoseproduktion (med op til en tredjedel), forbedrer perifer insulinsensitivitet i muskel- og fedtv\u00e6v og bremser i beskeden grad intestinal glukoseabsorption. Det <em>ikke<\/em> stimulerer ikke insulinudl\u00f8sning og for\u00e5rsager ikke hypoglyk\u00e6mi alene.<\/li>\n<li><strong>Glipizide<\/strong> \u2014 lukker ATP-f\u00f8lsomme kaliumkanaler p\u00e5 pankreatiske betaceller, depolariserer dem og udl\u00f8ser calcium-medieret <strong>insulinudl\u00f8sning<\/strong>. Dette virker kun, mens betacellerne stadig producerer insulin (tidlig til midt type 2-diabetes).<\/li>\n<\/ul>\n<p>Sammen producerer de to mekanismer et fald i HbA1c p\u00e5 <strong>1,5\u20132,0 procentpoint<\/strong>, v\u00e6sentligt mere end metforminmonoterapi.<\/p>\n<h2 class=\"wp-block-heading\">Dosering og administration<\/h2>\n<p><strong>Startdosis:<\/strong> One tablet of Glynase-MF with the main meal (breakfast). If glycaemia is not controlled after 2&ndash;4 weeks, increase to one tablet twice daily &mdash; with breakfast and dinner.<\/p>\n<ul>\n<li><strong>Tag sammen med eller umiddelbart efter mad<\/strong> \u2014 reducerer metformins bivirkninger fra mave-tarmkanalen og matcher sulfonylureamidlets virkning med den postprandielle glukosestigning.<\/li>\n<li><strong>Titr\u00e9r langsomt.<\/strong> Graduelle dosisfor\u00f8gelser reducerer b\u00e5de mavebesv\u00e6r og hypoglyk\u00e6mi.<\/li>\n<li><strong>Tag ikke en dobbeltdosis, hvis en dosis er blevet glemt.<\/strong> Spring den glemte dosis over; tag den n\u00e6ste p\u00e5 det s\u00e6dvanlige tidspunkt.<\/li>\n<li><strong>F\u00f8r operation, intraven\u00f8s kontrast eller akut sygdom<\/strong> \u2014 hold medicinen tilbage og kontakt din l\u00e6ge.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Bivirkninger<\/h2>\n<p><strong>Fra metfoninkomponenten (normalt i de f\u00f8rste 1\u20132 uger):<\/strong><\/p>\n<ul>\n<li>Diarr\u00e9, kvalme, mavekramper, luft i maven<\/li>\n<li>Metallisk smag i munden<\/li>\n<li>Nedsat appetit<\/li>\n<\/ul>\n<p><strong>Fra sulfonylurea-komponenten:<\/strong><\/p>\n<ul>\n<li><strong>Hypoglyk\u00e6mi<\/strong> \u2014 rystelser, svedtendens, hjertebanken, sultf\u00f8lelse, forvirring. Behandles med 15 g hurtigtvirkende kulhydrat. H\u00f8jere risiko hos \u00e6ldre, overspringte m\u00e5ltider og nedsat nyrefunktion.<\/li>\n<li>Beskeden v\u00e6gtstigning (1\u20133 kg)<\/li>\n<li>Lejlighedsvis hududsl\u00e6t<\/li>\n<\/ul>\n<p><strong>Sj\u00e6ldent, men alvorligt:<\/strong><\/p>\n<ul>\n<li>Laktatacidose (fra metformin) \u2014 meget sj\u00e6ldent, n\u00e6sten altid ved akut nyreskade, sepsis eller hypoxi<\/li>\n<li>Vitamin B12-mangel (langvarig metformin) \u2014 kontroller \u00e5rligt<\/li>\n<li>Alvorlig hypoglyk\u00e6mi \u2014 kan kr\u00e6ve medicinsk indgreb, is\u00e6r hos \u00e6ldre eller ved nedsat nyrefunktion<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">L\u00e6gemiddelinteraktioner<\/h2>\n<p><strong>\u00d8ger risiko for hypoglyk\u00e6mi:<\/strong> insulin, andre antidiabetika, alkohol (is\u00e6r binge-drinking), trimethoprim\/sulfamethoxazol, fluconazol, clarithromycin, ACE-h\u00e6mmere, h\u00f8jdosis salicylater, ikke-selektive beta-blokkere (som ogs\u00e5 maskerer hypoglyk\u00e6misymptomer), MAO-h\u00e6mmere.<\/p>\n<p><strong>\u00d8ger risiko for laktatacidose (metformin):<\/strong> intraven\u00f8st jodholdigt kontrastmiddel, carbonanhydraseh\u00e6mmere (acetazolamid, topiramat), kationiske l\u00e6gemidler (cimetidin, dolutegravir, ranolazin).<\/p>\n<p><strong>Reducerer blodsukkers\u00e6nkende effekt:<\/strong> kortikosteroider, thiazid-diuretika, skjoldbruskkirtelhormoner, phenytoin, rifampicin, atypiske antipsykotika, orale pr\u00e6ventionsmidler.<\/p>\n<h2 class=\"wp-block-heading\">Who Should Not Take Glynase-MF?<\/h2>\n<ul>\n<li>Type 1-diabetes, diabetisk ketoacidose<\/li>\n<li>Sv\u00e6r nyreinsufficiens (eGFR &lt; 30 mL\/min\/1,73 m\u00b2)<\/li>\n<li>Akut eller ustabil hjerteinsufficiens<\/li>\n<li>Sv\u00e6r leversvigt<\/li>\n<li>Overf\u00f8lsomhed over for sulfonamider (sulfa)<\/li>\n<li>Akut sygdom med risiko for v\u00e6vshypoksi \u2014 sepsis, respirationssvigt, nyligt hjerteanfald<\/li>\n<li>Graviditet og amning \u2014 insulin foretr\u00e6kkes<\/li>\n<li>F\u00f8r og 48 timer efter intraven\u00f8s kontrastunders\u00f8gelse (hvis eGFR &lt; 60)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Opbevaring<\/h2>\n<p>Store Glynase-MF below 25&deg;C in a dry place, in the original blister pack. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">Ofte stillede sp\u00f8rgsm\u00e5l<\/h2>\n<h3 class=\"wp-block-heading\">Is Glynase-MF the same as taking metformin and glipizide separately?<\/h3>\n<p>Klinisk set ja \u2014 den faste dosiskombination indeholder de samme aktive stoffer i samme doser som de to tabletter taget sammen. Fordelen er f\u00e6rre piller, bedre overholdelse og typisk lavere pris. Ulempen er mindre dosisfleksibilitet: hvis en af komponenterne skal \u00e6ndres, skal FDC erstattes med de separate tabletter.<\/p>\n<h3 class=\"wp-block-heading\">When is Glynase-MF usually added to a diabetes regimen?<\/h3>\n<p>N\u00e5r metformin som monoterapi i maksimalt tolereret dosis ikke l\u00e6ngere kontrollerer HbA1c. De fleste retningslinjer (ADA, EASD, NICE) anbefaler at tilf\u00f8je et andet l\u00e6gemiddel, n\u00e5r HbA1c er &gt; 7,5% ved kun metformin. Sulfonylurinstof er et bredt anvendt andetvalg, fordi det er billigt og effektivt, selvom DPP-4-h\u00e6mmere og SGLT-2-h\u00e6mmere nu foretr\u00e6kkes hos personer med hjerte- eller nyrelidelser.<\/p>\n<h3 class=\"wp-block-heading\">Can Glynase-MF cause low blood sugar (hypoglycaemia)?<\/h3>\n<p>Yes &mdash; because it contains a sulfonylurea. Skipping meals, unusual exercise, alcohol, and certain drug interactions raise the risk. Always take Glynase-MF with food and carry fast-acting carbohydrate. Severe or prolonged hypoglycaemia needs medical review.<\/p>\n<h3 class=\"wp-block-heading\">Will Glynase-MF cause weight gain?<\/h3>\n<p>Beskeden v\u00e6gt\u00f8gning (1\u20133 kg) er almindelig p\u00e5 grund af sulfonylurinstofkomponenten. Metformin er v\u00e6gtneutral eller lettere v\u00e6gtreducerende, s\u00e5 den faste kombination for\u00e5rsager normalt mindre v\u00e6gt\u00f8gning end sulfonylurinstof som monoterapi.<\/p>\n<h3 class=\"wp-block-heading\">Can I drink alcohol while taking Glynase-MF?<\/h3>\n<p>Moderat alkoholindtag sammen med mad er generelt sikkert. Undg\u00e5 binge-drinking og alkohol p\u00e5 tom mave \u2014 begge \u00f8ger risikoen for hypoglyk\u00e6mi (fra sulfonylurinstoffet) og laktatacidose (fra metformin).<\/p>\n<h3 class=\"wp-block-heading\">Skal jeg stadig tjekke mit blodsukker?<\/h3>\n<p>Ja, is\u00e6r i de f\u00f8rste 2\u20134 uger, efter dosis\u00e6ndringer eller under sygdom. HbA1c b\u00f8r kontrolleres hver 3.\u20136. m\u00e5ned.<\/p>\n<h3 class=\"wp-block-heading\">Where can I buy Glynase-MF online?<\/h3>\n<p>You can order Glynase-MF (5 mg + 500 mg) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide, with discreet packaging and genuine WHO-GMP certified manufacturer stock.<\/p>\n<h2 class=\"wp-block-heading\">Relaterede diabetesmedikamenter<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/da\/glycomet-sr\/\">Glycomet SR \u2014 Metformin med langsom frigivelse<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/amaryl\/\">Amaryl \u2014 Glimepiride 1\/2\/4 mg (Sanofi)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/januvia\/\">Januvia \u2014 Sitagliptin (DPP-4-h\u00e6mmer)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/jardiance-empagliflozin\/\">Jardiance \u2014 Empagliflozin (SGLT-2-h\u00e6mmer)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/forxiga-dapagliflozin\/\">Forxiga \u2014 Dapagliflozin (SGLT-2-h\u00e6mmer)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/janumet\/\">Janumet \u2014 Sitagliptin + Metformin kombination<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/diabetes-medication\/\"><strong>Se alle diabetesmedicin<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Medicinsk ansvarsfraskrivelse.<\/strong> Denne side er kun til informationsform\u00e5l og erstatter ikke l\u00e6gevejledning fra en kvalificeret sundhedsfaglig person. Sulfonylurinstof + metformin-kombinationer kan for\u00e5rsage hypoglyk\u00e6mi og (sj\u00e6ldent) laktatacidose \u2014 brug altid under l\u00e6gelig vejledning med regelm\u00e6ssig overv\u00e5gning af blodsukker, nyrefunktion og vitamin B12.<\/div>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-diabetes-starter-pack\">If you want the standard ADA\/EASD step-up sequence \u2014 metformin first, then metformin + sulfonylurea \u2014 bundled in one shipment, our <a href='\/da\/diabetes-starter-pack\/'>Diabetes Starter Pack (Glycomet SR 1000 mg + Glycomet-GP)<\/a> offers both molecules at matched 1, 3, or 6-month tiers, sourced from the most-prescribed Glycomet line.<\/p>\n<p class=\"medsbase-link-boost-2026-05-08\" data-marker=\"mb-link-boost-glycomet-sr\">When the glipizide component of <a href=\"https:\/\/medsbase.com\/da\/glynase-mf\/\">Glynase-MF<\/a> is discontinued and metformin monotherapy continued, <a href=\"https:\/\/medsbase.com\/da\/glycomet-sr\/\">Glycomet SR (metforminhydrochlorid 500\u20131000 mg SR)<\/a> is the natural extended-release step-down option, maintaining the same insulin-sensitising mechanism without the sulphonylurea component.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Relaterede alternativer<\/h3>\n<p>Andre produkter inden for <strong>Kroniske tilstande<\/strong> som kunder ogs\u00e5 ser:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/da\/rami-race\/\">Rami Race<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/lipvas\/\">Lipvas<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/hyloric\/\">Hyloric<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/glynase-xl\/\">Glynase Xl<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/metolar\/\">Metolar<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Regulerer blodsukker<br \/>\n\u2705 H\u00e5ndterer diabetes effektivt<br \/>\n\u2705 Combats insulin resistance<br \/>\n\u2705 Reducerer glukoseniveauer<br \/>\n\u2705 Forbedrer insulinf\u00f8lsomhed<\/p>\n<p>Glynase-MF contains Glipizide and Metformin.<\/p>","protected":false},"featured_media":61638,"comment_status":"closed","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3230,3231],"product_tag":[3257,5073,3255],"class_list":{"0":"post-61637","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-diabetes","9":"product_cat-diabetes-medication","10":"product_tag-glipizide","11":"product_tag-glynase-mf","12":"product_tag-metformin","14":"first","15":"instock","16":"shipping-taxable","17":"purchasable","18":"product-type-variable","19":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product\/61637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/comments?post=61637"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/media\/61638"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/media?parent=61637"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_brand?post=61637"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_cat?post=61637"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_tag?post=61637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}